SPANGARO, MARCO
 Distribuzione geografica
Continente #
EU - Europa 323
NA - Nord America 194
AS - Asia 160
SA - Sud America 10
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 694
Nazione #
US - Stati Uniti d'America 193
IT - Italia 152
SE - Svezia 81
CN - Cina 73
SG - Singapore 52
RU - Federazione Russa 27
IN - India 14
DE - Germania 12
IE - Irlanda 12
FR - Francia 8
GB - Regno Unito 8
FI - Finlandia 7
NL - Olanda 6
BR - Brasile 4
EC - Ecuador 4
IL - Israele 4
TR - Turchia 4
BD - Bangladesh 3
EG - Egitto 3
ES - Italia 3
CO - Colombia 2
GR - Grecia 2
HR - Croazia 2
IR - Iran 2
LY - Libia 2
MY - Malesia 2
PT - Portogallo 2
TW - Taiwan 2
AU - Australia 1
EU - Europa 1
HK - Hong Kong 1
IQ - Iraq 1
JP - Giappone 1
KR - Corea 1
MK - Macedonia 1
MX - Messico 1
Totale 694
Città #
Milan 46
Singapore 35
Shanghai 33
Ashburn 20
Rome 14
Boardman 12
Dublin 12
Lawrence 11
Princeton 11
Genoa 10
New York 10
Helsinki 7
Pune 7
Dalton 6
Seattle 6
Verona 6
Beijing 5
Dallas 5
Ferrara 5
Moscow 5
Padova 5
Secaucus 5
Fortaleza 4
Guangzhou 4
Jiaxing 4
Southwark 4
Washington 4
Cairo 3
Chengdu 3
Dhaka 3
Guwahati 3
Munich 3
Quito 3
Amalfi 2
Amsterdam 2
Ankara 2
Bergamo 2
Brugherio 2
Campi Bisenzio 2
Chongqing 2
Council Bluffs 2
Cuzieu 2
Cyberjaya 2
Fuzhou 2
Geldrop 2
Guimarães 2
Hanover 2
Izmir 2
Los Angeles 2
Lyon 2
Manizales 2
Mozzo 2
Mulhouse 2
Naples 2
Pátrai 2
Rehovot 2
Rieti 2
Sesto San Giovanni 2
Shenzhen 2
Skowhegan 2
Taipei 2
Tradate 2
Travaco Siccomario 2
Tripoli 2
Union City 2
Verdellino 2
Wirral 2
Zagreb 2
Adelaide 1
Asti 1
Bradford 1
Bristol 1
Cagliari 1
Cuenca 1
Foshan 1
Guadalajara 1
Görwihl 1
Hamden 1
Jacksonville 1
Jerusalem 1
Meduna di Livenza 1
Memphis 1
Nuremberg 1
Paris 1
Skopje 1
Songpa-gu 1
Tokyo 1
Tremestieri Etneo 1
Treviso 1
Waldshut-Tiengen 1
Weitang 1
Wuhan 1
Totale 408
Nome #
COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA: DISENTANGLING THE ROLE OF METABOLIC ALTERATIONS AND NEUROINFLAMMATION 80
Schizophrenia and psychedelic state: Dysconnection versus hyper-connection. A perspective on two different models of psychosis stemming from dysfunctional integration processes 55
The cognitive architecture of verbal humor in schizophrenia 35
Cognitive Remediation for Inpatients With Schizophrenia: Effects of a Brief and Intensive Training 30
Targeting quality of life in schizophrenia: the fil rouge between metabolic syndrome and anxiety 29
Modeling the interplay of age at onset and sex on cognition in Schizophrenia 28
Communicative-pragmatic abilities mediate the relationship between cognition and daily functioning in schizophrenia 28
Combined effect of treatment-resistance and autistic traits on sociocognitive abilities in schizophrenia 27
M202. SEX-RELATED DIFFERENCES IN CLOZAPINE SIDE EFFECTS IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA 26
Clozapine tolerability in Treatment Resistant Schizophrenia: exploring the role of sex 26
Get up! Functional mobility and metabolic syndrome in chronic schizophrenia: Effects on cognition and quality of life 26
Clozapine to N-Desmethylclozapine ratio in treatment resistant schizophrenia: clinical implications from psychopathology to cognition 24
Disentangling Cognitive Heterogeneity in Psychotic Spectrum Disorders 24
Cognitive reserve profiles are associated with outcome in schizophrenia 21
Psychotic Disorders 19
Factors affecting cognitive remediation outcome in schizophrenia: The role of treatment resistance 19
S67. TREATMENT-RESISTANCE AFFECTS LONG-TERM COGNITIVE TRAJECTORIES IN SCHIZOPHRENIA: A LONGITUDINAL STUDY 19
Obsessive-compulsive symptoms moderates the effects of cognitive functioning on quality of life in clozapine-treated schizophrenia 18
Cognitive remediation in schizophrenia: What happens after 10 years? 18
Cognition in Schizophrenia: Modeling the Interplay between Interleukin-1β C-511T Polymorphism, Metabolic Syndrome, and Sex 18
Deconstructing heterogeneity in schizophrenia through language: a semi-automated linguistic analysis and data-driven clustering approach 17
On the Implementation of Computerized Adaptive Observations for Psychological Assessment 17
Longitudinal course of cognition in schizophrenia: Does treatment resistance play a role? 17
Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies 16
Functional benefits of co-occurring autistic symptoms in schizophrenia is delimited by symptom severity 16
Improving outcome of treatment-resistant schizophrenia: effects of cognitive remediation therapy 16
Is longer treatment better? A comparison study of 3 versus 6 months cognitive remediation in schizophrenia 16
White matter integrity, clinical symptoms and quality of life in schizophrenia: a DTI study 15
The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy 12
Treatment-resistance as a predictor of cognitive remediation outcome in schizophrenia 11
Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions 11
Dysconnection in schizophrenia: Filling the dots from old to new evidence 10
null 6
Psychedelics and schizophrenia: a double-edged sword 2
Totale 752
Categoria #
all - tutte 7.107
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.107


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 6 3 0 0 0 0 0
2021/202223 0 0 0 8 4 0 0 0 3 1 5 2
2022/2023201 28 21 8 3 26 28 16 24 7 9 17 14
2023/2024255 30 21 27 23 21 33 6 27 0 8 10 49
2024/2025264 82 37 55 59 31 0 0 0 0 0 0 0
Totale 752